Related Experiment Video

Updated: Aug 12, 2026

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat
08:27

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Prophylaxis of bacterial meningitis

H Peltola1

  • 1Department of Infectious Diseases, Helsinki University Central Hospital, Finland.

Infectious Disease Clinics of North America
|September 2, 1999
PubMed

Insights

Bacterial meningitis prevention through vaccination and chemoprophylaxis is reviewed. New conjugate vaccines show promise for meningococcal and pneumococcal diseases, but cost remains a barrier.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Bacterial meningitis poses a significant global health threat, primarily caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B (Hib).
  • Effective prevention strategies are crucial to reduce morbidity and mortality associated with these infections.

Purpose of the Study:

  • To review major bacterial meningitis pathogens and discuss prevention strategies, including chemoprophylaxis and vaccination.
  • To evaluate the potential of existing and emerging vaccines for controlling meningococcal, pneumococcal, and Hib meningitis.

Main Methods:

  • Comprehensive literature review of studies on bacterial meningitis agents.
  • Analysis of data on the efficacy and availability of chemoprophylaxis and vaccines.
  • Assessment of novel conjugate vaccine technologies and their implications for immunoprophylaxis.

Main Results:

  • Chemoprophylaxis and vaccination are key strategies for preventing meningitis caused by meningococcus (groups A, B, C, W135, Y), pneumococcus, and Hib.
  • A vaccine for serogroup B meningococcal disease may be available and effective.
  • Conjugate vaccines utilizing advanced techniques show potential to revolutionize prevention of meningococcal and pneumococcal diseases.

Conclusions:

  • Vaccination and chemoprophylaxis are essential for controlling major bacterial meningitis pathogens.
  • Emerging conjugate vaccine technologies offer significant promise for future meningitis prevention.
  • High costs of conjugate vaccines present a substantial challenge to their widespread implementation, particularly in low-income countries.

More Related Videos

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...